Celebrating 25 Years of Pioneering Stories of…

Impact Seeker

Jerri Wang

Chief of Staff, Senior Director, Head of Portfolio Strategy and Operations for a Flagship Pioneering Business Unit

I pioneer to seek impact by imagining the future and helping to make it happen.

As Chief of Staff for one of Flagship Pioneering’s Business Units, Jerri Wang helps build and scale novel technology companies that are expanding Flagship's impact beyond biotechnology. Working at the intersection of company creation, strategy, and operations, she helps turn future-focused ideas into AI, software, and device companies that solve meaningful problems in entirely new ways.

On a day-to-day basis, Jerri partners with entrepreneurs, AI and software specialists, and colleagues across finance, legal, and other functions to help build what she describes as "the best venture studio possible." By developing the systems and processes that support company creation, she enables her team to focus on imagining, launching, and growing breakthrough technology companies.

An example is Extuitive, a company built on the idea that AI can help us understand human behaviors and preferences at scale. Extuitive applies AI to help companies make smarter marketing decisions and reduce wasted spend.

Bringing a vision like Extuitive to life requires people with diverse expertise working toward a shared purpose. For Jerri, that collaborative spirit is one of Flagship's defining strengths. Working alongside exceptionally smart and driven people is one of the things she finds most energizing about Flagship. When you're creating something that has never existed before, there is no roadmap, and often no historical data to provide direction. Progress comes from bringing together different perspectives to develop hypotheses, explore new possibilities, test ideas, and learn quickly from the results.

We do entrepreneurship as a team; something I find very inspiring.

Whether discussing technology, the forces shaping society, or the future of entire industries, Jerri is part of a community united by a passion for asking big questions. She believes curiosity is the starting point for innovation, and that meaningful discoveries emerge from conversations that challenge assumptions and expand what's possible. Those conversations influence the way she thinks about the future and the companies her team is building.

For Jerri, that curiosity naturally extends to AI. She sees it as one of the biggest opportunities to create meaningful impact, describing it as the industrial revolution of our time. It has shaped not only the companies she helps build, but also how her team operates.

She has fostered an AI-native operating model where her team is empowered to develop AI agents that support everything from knowledge gathering to project management. By starting every project with the best available thinking and turning new skills into shared capabilities, the team continuously learns, improves together, and spends more time applying creativity, judgment, and imagination to high-impact work. She believes AI's true potential lies not only in automating work, but in helping people focus on the problems that matter most while amplifying human creativity and intelligence.

AI is just the latest chapter in Jerri's lifelong pursuit of impact. She describes herself as an "impact seeker," a mindset that has guided every stage of her career. She earned her PhD in Biological Chemistry at the University of Pennsylvania, researching proteins associated with Parkinson's disease. While inspired by the potential of scientific discovery, she was drawn to opportunities that could move ideas more quickly from discovery to meaningful application. That drive led her to consulting, and ultimately to Flagship, where she now helps create technologies and businesses that don't yet exist.

We're not focused on the next generation of technology. We're thinking three, four, or five generations ahead and accelerating the paths to get there.

Jerri's career has been defined by a desire to create meaningful impact. At Flagship, she has found a place where collaboration, intellectual curiosity, and ambitious thinking come together to imagine the future and build companies that help make it a reality.

There must be a much better scientific way.

Metabolic Maverick

Rajib Mukherjee

Associate Director, Pioneering Medicines

I pioneer to be part of something novel and life-changing, to push forward bold, out-of-the-box ideas, and to help develop a drug that truly impacts human health.

Rajib Mukherjee is an Associate Director in Pioneering Medicines’ Biology Pharmacology group. He leads in vitro biology and pharmacology research to uncover new approaches to obesity management and metabolic disease treatments and plays a key role in the company’s collaboration with Novo Nordisk.

I feel fortunate to be exploring entirely new frontiers in biology. Exploring new ideas pushes me to do more.

Rajib’s pioneering journey began in West Bengal, India, where his fascination with biology was shaped by his close interactions with nature. His bachelor’s and master’s degrees in plant biology introduced him to the complexities of plant-microbe interactions, particularly how plants communicate with soil bacteria to extract nutrients. While earning his master’s degree, he was challenged to identify an unresolved question in biology and propose a solution—a transformative research exercise that ignited his passion for discovery and problem-solving and led him to pursue a PhD at Daegu University in South Korea.

Rajib’s PhD research evolved from studying plant microbiomes to exploring plant-derived molecules for human health. His work on the metabolic effects of plant-derived molecules bridged his transition from plant to human biology, providing him with a unique perspective for drug discovery and human metabolic disease research.

Determined to continue this research, he was accepted to a postdoctoral program at Cincinnati Children’s Hospital Medical Center, where his work on metabolic diseases earned him the American Heart Association’s fellowship. While working in a hospital, he witnessed firsthand the profound impact therapeutics can have on patients' lives. This experience inspired him to channel his expertise into addressing pressing healthcare challenges, eventually leading him to a career in biotech and to Flagship’s Pioneering Medicines.

For Rajib, pioneering means creating something truly novel and life-changing by asking bold questions, redefining possibilities, and navigating complex scientific challenges. Inspired by his pioneering mentors, colleagues, and team members, his goal is to one day deliver a market-ready drug with a lasting impact on human health.

If you're part of a drug development process that not only hits the market but stays successful and endures, you're truly one of the lucky ones—a dream come true for anyone.

Mindset Trainer

Louisa Helms

Senior Associate

I pioneer to pave new paths that can open up entirely new possibilities in science.

Louisa Helms, is a Senior Associate at Flagship Pioneering, where she is immersed in company origination and translating cutting-edge science into transformative solutions for human health.

Her career path has been driven by her desire to connect groundbreaking science with its commercial potential. After earning her Ph.D. in Molecular Medicine and Mechanisms of Disease, she realized that she was more interested in guiding companies and shaping strategy than doing hands-on research.

While gaining entrepreneurial experience at a biotech startup, she observed a communication gap between scientists and investors. Scientists often struggled to convey the value of their innovations, while investors found it difficult to grasp the science behind them. Louisa bridged that gap by learning to communicate complex ideas in clear, accessible ways, helping diverse audiences understand the science and see its company-building possibilities. This involved applying a strategic lens to scientific concepts, business models, and operational frameworks, to create actionable roadmaps for advancement—abilities that ultimately led her to Flagship.

Louisa joined Flagship in 2022 and quickly became embedded in an early-stage company. From day one, she embraced every challenge with determination and was committed to doing whatever it takes to drive innovation and prepare the company for its next stage of growth. She has been instrumental in scaling the team from five to more than forty and has worn many hats along the way—from leading cell biology teams and advancing therapeutic workstreams to guiding corporate and intellectual property strategy.

The real joy comes from the hard work you put into something, especially when it’s a difficult task and you make it succeed.

Louisa brings a blend of scientific rigor, strategic insight, and entrepreneurial vision to her role, ensuring that every endeavor she champions has a clear, long-term purpose worth achieving. More than just driving growth, she takes pride in articulating and influencing both scientific and operational decisions, giving high-risk ideas the structure and support to succeed.

Louisa credits a training mindset with helping her navigate challenges along the way. Grounded in continuous learning, practice, and refinement, this approach strengthens her adaptability, fuels her pursuit of ambitious goals, and equips her to face the unknown with confidence.

Staying true to her training mindset, Louisa tackles personal goals—like mastering a handstand—with the same determination she brings to her work. She has spent hours failing and making incremental progress, proving that persistence pays off in any pursuit, whether scientific discovery, strategic innovation, or balancing upside down for only a few seconds. For Louisa, every small step is part of a bigger leap toward pioneering what’s possible.

I apply a training mindset to everything that I do. If I have a skill that I'm not good at, I will train it incessantly.

Imagination Agent

Lakshmi Nair

Senior Machine Learning Scientist, Pioneering Intelligence

I pioneer because it’s challenging and gives me a very unique opportunity to push the boundaries of machine learning and my own knowledge while helping to make a positive impact on the world.

As a Senior Machine Learning Scientist on Flagship’s Pioneering Intelligence Technology Team, Lakshmi Nair is focused on machine learning methods to advance AI's creativity and enabling systems to solve complex problems autonomously, paving the way for more adaptive, intelligent AI that supports scientific discovery and breakthroughs.

During her PhD research, the exploration of an uncharted area of robotics — creative problem-solving — inspired Lakshmi’s passion for AI. Robots are typically assumed to have all the tools they need, but she challenged this assumption, asking, "What if a robot doesn’t have the tools it needs? How can it improvise?" This research demonstrated that robots could repurpose objects in their environment, a concept that opened a new frontier in robotics. This experience reinforced her curiosity for solving big problems.

Lakshmi’s work at Flagship may also have profound applications, particularly in therapeutic development, drug discovery, and protein synthesis. Her work focuses on designing AI agents that can analyze vast scientific literature, generate hypotheses, and automate research, increasing efficiency and accelerating breakthroughs. Beyond healthcare, her AI models could transform fields from autonomous research and development to scientific decision-making, expanding the possibilities of AI-driven innovation.

I connect with the idea of multi-potentiality — embracing multiple creative pursuits rather than confining yourself to one field. When you narrow your focus, you limit your capacity for breakthroughs.

Lakshmi’s pioneering role model is the concept of multi-potentiality, a celebration of individuals with diverse interests, intellectual pursuits, and interlocking potentials. She discovered this idea in Emilie Wapnick’s TED Talk and immediately resonated with its message and her interdisciplinary scientific approach that bridges fields like cognitive psychology, neuroscience, and physics to redefine how AI can think creatively.

For Lakshmi, pioneering isn’t just about advancing AI, it’s about inspiring others to think broadly and differently. She hopes her work encourages future scientists to push boundaries, ask bold questions, and tap into their own creativity to develop impactful technology.

I try to be as creative as I can in my own work, and I hope that it will inspire others to also tap into their creativity as they develop impactful technology and let their imagination show through.

Cure Hunter

Kathy Phillips

Vice President, Program Management, Pioneering Medicines

I pioneer to make a positive impact on patients’ lives, knowing that even one life changed for the better makes it all worthwhile.

Kathy Phillips is Flagship’s Vice President of Program Management for Pioneering Medicines, where she leads efforts to translate breakthrough science into meaningful therapies. She oversees a portfolio of more than a dozen drug programs across diverse therapeutic areas, guiding each through the key stages of discovery and development. With her background as an immunologist and a clinical drug development professional, Kathy brings a blend of scientific acumen and operational discipline to the complex challenge of hunting for cures.

Her journey into science began with a strong curiosity about how the human body works. As a student, she gravitated toward cell biology, drawn to the puzzle of how cells communicate and function together. Early in her career, while working on a therapy to heal wounds caused by diabetes, Kathy heard a patient describe the treatment’s life-changing impact. That moment became a turning point. It showed her that her work wasn’t just about running experiments in the lab and collecting data; it was about transforming lives.

We call it research for a reason—you redo it again and again, taking steps forward and back, often far from the patients you hope to help. But when the science finally reaches them, that’s when it all matters.

Before joining Flagship, Kathy worked at a global biopharmaceutical company, where she helped lead a phase-3 multiple sclerosis program. Kathy and her team were responsible for overseeing the FDA New Drug Application (NDA) for that program and guided it all the way to approval.

The approval was a significant milestone. The moment was especially meaningful for Kathy, as a close family member suffers from multiple sclerosis, which gave her a deep understanding of the disease’s devastating impact. Seeing the therapy on the market and available to patients was a surreal and powerful reminder that perseverance, collaboration, and a deep commitment to patients can turn years of dedication into something that changes lives.

If people knew how much it takes to turn an idea for a medicine into something ready to test in humans, they’d realize it’s anything but a straight path — it’s tough, unpredictable, and deeply rewarding.

At Pioneering Medicines, Kathy leads programs that span therapeutic areas including metabolic disease, immunology, oncology, and liver conditions, and across modalities such as cell biology, nucleic acids, antibodies, and small molecules. Because her group can draw from the novel science being created across Flagship’s ecosystem of platform companies and leverage external partnerships and collaborations, the team isn’t limited to one or two therapeutic areas like traditional biopharma organizations often are. As a result, Pioneering Medicines is uniquely positioned to translate science into patient benefit at an accelerated pace.

Her scientific curiosity and dedication to improving human health continue to drive her work. Looking ahead, Kathy hopes her legacy will be a generation of program leaders who lead with clarity and courage. And, having already guided a therapy to patients, she aspires to do so again through the pioneering science at Flagship.

Innovation Enabler

Aranza Ballesteros

Associate Director, HR Operations

I pioneer to design processes that make space for creativity, discovery, and innovation to flourish.

Aranza Ballesteros is an Associate Director of Human Resources Operations at Flagship Pioneering. She is responsible for supporting people operations across the Flagship ecosystem, and partners with HR teams to define and standardize the systems that guide the employee experience. Her approach to operations is focused on creating streamlined, consistent, and efficient processes that allow employees to spend more time on the science and creativity that drive innovation forward.

Detail-oriented and analytical, Aranza is fascinated by how well-designed systems and strong relationships shape organizations and can influence how they evolve over time. She’s drawn to structures and logistics that keep things running smoothly and to the alignment of processes, data, and people. For Aranza, operations is both a craft and a puzzle, one that requires her to bring order and insight to everything she builds.

I’m motivated by the chance to grow, to explore new ideas, to be creative, and to make a positive impact on the people around me.

Before joining Flagship, Aranza played a key role in designing and globalizing recruiting processes for a multinational company. She learned firsthand how challenging and rewarding it can be to create systems that uphold global standards while respecting the distinct cultures and practices of local teams. Through that work, she discovered that thoughtfully crafted processes can also create inclusivity and engagement. The experience informed her own view of leadership and taught her that the best systems also make space for people to achieve more together across diverse cultures.

Her experience as an immigrant has also given her a unique perspective rooted in resilience and possibility; a perspective that naturally aligns with Flagship’s pioneering spirit. Coming to the United States from Mexico as a child taught her to adapt quickly, face change with openness, and stay determined through uncertainty. She brings that mindset to her work, treating every challenge as a chance to learn and every new idea as an opportunity to continuously improve.

Aranza’s connection to Flagship’s mission is deeply personal. After witnessing a family member’s life transformed by a new medical procedure, she came to understand how innovation can expand the boundaries of what’s possible. That experience continues to inspire her work, reminding her of the power of pioneering to create profound change in people’s lives.

Aranza hopes that her efforts will help build lasting impact through processes that evolve, relationships that strengthen over time, and an environment that grows with its people – allowing them to contribute in meaningful ways and push the boundaries of discovery.

When people feel supported and empowered, they can do their best work. I’m inspired by creating tools to help make that possible.

Biotech Surfer

Nick Plugis

Senior Principal

I pioneer to dream about and discover medical possibilities.

Nick Plugis is a Senior Principal at Flagship Pioneering, where he transforms bold scientific ideas into groundbreaking companies. He pioneers new company origination by developing bioplatforms and thrives in an environment that reimagines the future of science. His work has helped launch and scale innovative Flagship companies such as Ring Therapeutics, Sail, Ampersand, Abiologics, and Cellarity, where he also served as Chief Innovation Officer.

Flagship provides an opportunity to remove the fiction from science fiction and turn it into something real. As a scientist, it’s just so much fun.

As a child, Nick and his brother were so eager to explore nature and science that they transformed their bedroom into a personal lab, which became a haven for experiments. Whether by altering the chemistry of a penny or viewing unseen worlds through a microscope, Nick’s childhood lab nurtured a fascination for the “magic of science” and his imagination for scientific discovery grew stronger.

While Nick always had a love for science, a pivotal moment solidified his commitment to discover ways to use science to benefit others. During college he became severely ill with a rare disease. The frightening experience led him to question everything, and after months of searching for answers, modern medicine saved his life. This transformative experience inspired him to dedicate himself to ensuring others have access to life-changing breakthroughs like those that saved him.

New science that is able to really have an impact on patients, to improve their lives in profound ways, is always my goal.

Driven by this purpose, Nick earned a PhD at Stanford, immersing himself in biology, translational science, and the University’s entrepreneurial spirit. This blend of disciplines eventually drew him to Flagship Pioneering and its unique environment where bold scientific ideas become companies and where he could learn directly from seasoned innovators, entrepreneurs, and scientists.

Nick’s pioneering spirit isn’t limited to the office or lab. He is an avid surfer and likens the thrill of surfing to pioneering science—both requiring courage and ability to ride uncertainty towards the next wave of discovery. Inspired by history’s great pioneers like Galileo, Da Vinci, and Thomas Edison, he believes that true pioneers do more than advance science; they reshape the future. Now raising a family of his own with his wife, Elise, Nick envisions a world where his work helps ensure life-saving innovations are the norm for future generations.

I'm amazed by the breakthroughs emerging from scientific teams uniting nature's wisdom with the power of computation. It's inspiring to be part of this renaissance of discovery and innovation.

Curious Collaborator

Erica Weinstein

Vice President, Flagship Labs Strategy & Development

I pioneer to turn bold questions into breakthrough impact through the power of science, curiosity, and collaboration.

As Vice President of Flagship Labs Strategy and Development, Erica Weinstein thrives at the intersection of science, business, and collaboration, in a role that spans company origination and corporate development. On any given day, she might identify new internal collaborations, find channels to advance scientific ideas, or steward external relationships with organizations like Samsung, Thermo Fisher Scientific, and Analog Devices. It’s dynamic, evolving work that taps into the breadth of her purpose, training, and experience.

Erica’s interest in science took shape in middle school, after her father’s devastating diagnosis of non-Hodgkin’s lymphoma. Fortunately, he was one of the first patients to have access to a novel monoclonal antibody immunotherapy that not only treated his cancer but also alleviated a chronic autoimmune condition. Witnessing the life-changing impact of a cutting-edge medicine opened Erica’s eyes to the transformative power of scientific innovation and inspired her to learn more about biology, drug discovery, and the biotech industry.

Erica’s curiosity deepened when she was in high school and secured a summer internship in the flow cytometry lab of well-known University of Pennsylvania pathologist, Dr. Jonni Moore. On her first day, she was seated at the flow cytometer — an advanced instrument to analyze and measure the physical and chemical properties of millions of individual cells at a time — and told to “play around and figure it out.” She quickly learned to understand antibody panels and interpret the data. By the end of the summer, her research was included in a published scientific paper. This experience revealed that science thrives on uncertainty and, with the support of a mentor and hands-on exploration, can turn mere curiosity into discovery.

Collaboration goes beyond sharing ideas. It creates a space to inspire innovation.

While earning her PhD in immunology, Erica found herself constantly challenging assumptions and asking “what if” questions. This mindset naturally aligned with Flagship’s ethos and led her to join the company after completing the Flagship Fellowship in 2015. Before stepping into her current role leading Flagship Labs strategy and development in early 2024, she spent eight years creating and building companies, including Ring Therapeutics. At Ring, she and her team took on the challenge of studying, isolating, and engineering anelloviruses — an area of virology that had previously never been demonstrated. Despite widespread skepticism, they succeeded in their efforts, which paved the way for the development of Ring’s Anellogy™ platform, a pioneering gene-delivery system. For Erica, this experience underscored the importance of bold thinking and how collaborating in teams and uniting around shared ideas can drive impact and make the seemingly impossible possible.

Creating impact is not just about advancing a single company — it’s about helping the Flagship ecosystem move smarter and faster together.

Erica channels this approach into driving cross-functional collaboration at Flagship — most notably through her efforts to support an internal forum for idea exchange and strategic alignment. Results of these discussions have led to the development of a shared, Flagship-wide database of assays, equipment, and capabilities — a tool that will help enable strategic consistency and resource optimization. This dynamic platform is also playing a central role in advancing global partnerships and Flagship initiatives like Enabling Technologies, Pioneering Medicines, Pioneering Intelligence, and Preemptive Health and Medicine. By driving cross-company collaboration and convening the right people around shared priorities, Erica is helping Flagship move more swiftly and strategically toward its mission of creating lasting impact.

Looking ahead, Erica is focused on expanding scientific curiosity, meaningful connection, and dynamic collaboration across Flagship to help usher in new waves of innovation and redefine what's possible in science and medicine.

Polydisciplinarian

Ayşe Muñiz

Principal

I pioneer to build a more hopeful future. And because it’s fun!

Ayşe Muñiz joined Flagship Pioneering in 2020 after completing the Flagship Pioneering Fellowship. She initially focused on helping Pioneering Medicines establish its exploration team to seed ideas for its pipeline. She is now a Principal originating companies and leading a startup that applies AI to provide insights into mental wellbeing. She is also integrating AI into Pioneering Medicines and uniting teams to enhance therapeutic innovation.

Ayşe’s passion for science was influenced by experiencing the personal impact of societal problems, including physical and mental health struggles in her family. In college, she was fortunate to receive scholarships and fellowships that allowed her to work in research settings. One of her first research experiences was at the University of New Mexico, where she worked on nanotechnology for nucleic acid delivery — a project that resulted in her first patent and cemented her career path in science and innovation.

I refuse to stay in a lane. I really rejoice in being an interdisciplinary thinker.

Her background in biochemistry and tissue engineering, combined with collaborations with chemical engineers, materials scientists, and clinicians, has given her a 360-degree perspective on problem solving. She takes an interdisciplinary approach to innovation, asking how an engineer, scientist, business strategist, or even an artist would tackle any given challenge. At Flagship, her efforts across diverse fields reinforce her belief that blending perspectives fuels creativity and fosters collaboration.

Ayşe takes pride in mentoring Flagship fellows and associates, many of whom have excelled in their own careers. Yet, she believes her greatest achievement is still ahead and hopes her journey inspires others, particularly young women. As a first-generation college student from a rural area, she demonstrates that no dream is out of reach.

Belief is kind of the currency for reality, and your conviction is what's going to drive the motivation and inspire a team to join and do the work.

Among the pioneers who inspire her, two stand out: Marie Curie, the two-time Nobel Laureate who revolutionized our understanding of radioactivity, and her grandmother, an immigrant from Istanbul who built a life in the U.S. as a single mother running a beauty business and whose resilience instilled in Ayşe a deep belief in perseverance and possibility.

Outside of work, Ayşe channels her creativity into poetry, sculpting, and painting — activities that offer space for reflection and renewal. Drawn to philosophical texts that challenge her thinking, she continually broadens her perspective.

Whether through art or innovation, her journey — from personal challenges to pioneering AI-driven healthcare — embodies resilience, ambition, and enduring curiosity, that is shaping a more hopeful future.

The best way to apply my life is to put all of my energy into something and have that something be worthwhile.

Resource Diviner

Nathan Hancock

Operating Partner

I pioneer because I believe that by challenging the status quo and forging new paths, we can build a future of resource abundance for generations to come.

Nathan Hancock is an Operating Partner at Flagship Pioneering, where he originates innovative companies focused on resource security and generation and advances in materials science. Among other activities, he leads a start-up focused on re-envisioning how we access freshwater using biotechnology to proactively address water scarcity; enhance agricultural resilience; support disaster preparedness such as wildfire prevention and response; and reduce reliance on conventional water sources.

Nathan’s drive to create transformative change was forged early in life. His ancestors were pioneers of Colorado's gold rush, and he spent his earliest years in an abandoned mining town in Gilpin County — a landscape marked by generations of resource extraction and environmental damage so severe that the community lacked fresh drinking water. When Nathan was in elementary school, his family moved to a location that, while improved, was situated on the outskirts of an Environmental Protection Agency (EPA) Superfund site with lingering impacts from toxic mining. These formative challenges instilled a relentless desire to venture into uncertain territory and seek opportunities to create abundance and prosperity.

My backyard growing up was an acid mine drainage field where we played football, rode our bikes, and routinely waded through a soup of exotic algae and who knows what else.

Despite growing up with limited resources and few academic role models, Nathan’s determination and intellect opened many educational opportunities. He pursued technical education at the Colorado School of Mines, earning a B.S. in Geophysical Engineering and an M.S. and Ph.D. in Environmental Science and Engineering, with a focus on materials and process technology for water purification and resource efficiency — disciplines addressing the challenges he experienced growing up.

While completing his Ph.D., Nathan was recruited by Oasys Water, a Flagship Pioneering-backed company in Boston tackling water scarcity. Nathan’s work leading R&D at Oasys honed his technical skills and rapidly broadened his professional capabilities as well as perspective on the skills needed to translate innovations into successful commercial enterprises. This work led him to Harvard Business School where he received his MBA.

These diverse life, educational, and career experiences positioned Nathan well for his current role at Flagship, where he and his team explore daring ideas to find innovative, scalable solutions for pressing issues in energy, resources, the environment, and human health.

I'm confident that bold innovation will unlock the keys to securing the resources to feed, power, and enrich lives globally.

Nathan uses his journey from a small mining town to addressing humanity’s most critical challenges to inspire. Having once lacked mentors and support, he now guides young innovators in the field. And as an avid explorer and mountaineer, whose professional, humanitarian, and personal travels have taken him around the world, it’s not surprising that his pioneering role model is the Sherpa.

What the Sherpa does—cutting into the unknown, setting direction, guiding others through uncertainty, risk, and challenge — is quintessential to what it means to pioneer.

Scientific Storyteller

Josephine Zorbo

Senior Director, Communications

I pioneer because when science is communicated clearly and credibly, it has the potential to reach and transform the lives of those who need it most.

Josephine (Jo) Zorbo is a Senior Director of Communications at Flagship Pioneering, where she leads communications for many of Flagship’s emerging- and growth-stage portfolio companies. She turns complex science into narratives that shape a company’s voice and stories that convey the significance of their breakthroughs. Her work touches every facet of corporate communications, from creating messaging and developing brand and media strategies, to amplifying impact as companies scale.

Jo didn’t follow a traditional path to communications. Trained as a neuroscientist, she found during her Ph.D. that she was far more energized by learning and explaining how scientific discoveries evolve into platforms, technologies, and ultimately medicines than the hands-on lab work. When a mentor encouraged her to think about exploring careers outside of research and academia, she applied for and unexpectedly landed a role at a life science communications firm. It became a defining moment, revealing that she could remain immersed in cutting-edge science while building a purposeful career beyond the lab.

It’s so helpful to understand the science at a deep level when communicating what makes it exciting and unique. Exploring new areas of science and its applications is what inspires my work.

She quickly learned by doing, asking questions, and approaching every challenge as an invitation to learn more and continuously advance her expertise. This resourcefulness and agility define her work at Flagship, where she brings rigor and clarity to some of the most visionary science in biotech.

At Flagship, Jo’s scientific background is a strategic advantage. She plays a central role in introducing Flagship companies to the public and partners closely with Flagship’s scientific and business leaders to ensure they tell the right story to the right audience at the right time. Whether delivering nuanced communication about a company’s groundbreaking data or articulating the promise of a company’s scientific platform and the medicines it enables, Jo enthusiastically unpacks the complexities of these advances to create a compelling storyline. For Jo, communication is the bridge between breakthroughs and broader public understanding.

Launching new Flagship companies is incredibly fulfilling because you get to help shape how groundbreaking science is first introduced to the world.

Jo’s early work supporting communications for rare disease biotechs shaped her understanding of why this work matters. She frequently received inquiries from families desperately searching for yet-to-be discovered therapies and cures for their loved ones. These interactions were heartbreaking, but they also revealed the positive and profound impact transformative science can have on people’s lives when it informs new therapies, and the importance of communication in providing guidance and optimism when people need it most.

Jo believes science, and the therapies it yields, can create a better world, and that telling its story is both a privilege and a responsibility. She brings precision, credibility, and care to this work, and is dedicated to delivering well-communicated science to deepen understanding, honor discovery, and help build a healthier, more hopeful future.

It doesn’t matter if it’s new science, good science or even old science, science has extraordinary power. When it’s applied in the right ways to produce entirely new medicines, you realize just how much impact it can have.

Evolutionary

Sophie de Boer

Senior Principal

I pioneer to shape what comes next and help the world evolve into something better.

Sophie de Boer is a Senior Principal at Flagship Pioneering, where she is part of a team of entrepreneurial scientists, developing the novel biotechnologies, intellectual property, and business strategies that are foundational to the creation of Flagship’s breakthrough startups.

Since joining in 2017, she has played a key role in conceiving and launching six pioneering platform companies, in some of the most innovative areas of biotechnology. This includes reimagining the potential of mRNA, applying AI to protein generation, advancing cell therapies, and developing new approaches to nucleic acid delivery. Her expertise in stem-cell science, combined with broad academic research, also gives her the ability to effectively bridge ideas across multiple disciplines.

Sophie credits the natural world as the source of her scientific curiosity and discovery. Growing up in the Netherlands, she remembers witnessing metamorphosis firsthand, watching the frog eggs she collected transform into tadpoles, then into fully formed frogs. That early glimpse into the wonders of life ignited a sense of awe, one that continues to drive her passion for scientific exploration and innovation.

Reinvention has been a constant in her journey and is shaped by her experience as an immigrant living in the US, which has fostered adaptability, grit, and openness to diverse perspectives. These qualities not only reflect her pioneering spirit but deeply align with Flagship’s culture of resilience and continuous transformation.

If we don’t take risks, we’ll never move forward. People say, ‘shoot for the moon,’ but I’d rather shoot for Pluto. Worse case we’ll land on Mars.

In her role at Flagship, taking risks is a fundamental step on the path to scientific progress. It demands the courage to confront setbacks and the strength to let go of failures and begin again. Some scientific explorations advance to clinical candidates, while others are discontinued. These moments can be difficult and humbling but are the necessary detours that are integral to Flagship’s evolutionary approach to innovation and offer opportunities to expand collective knowledge and unlock possibilities.

Sophie thrives at the intersection of invention and execution, where ideas must evolve to survive, grow, and succeed. Just as metamorphosis represents a dramatic leap in biological development, the development of platform companies represents taking similar leaps. Helping to shape and guide the evolution of ideas and companies is not only central to her work, but also one of the most rewarding aspects of her role at Flagship.

Driving meaningful change means asking the hardest questions, taking the biggest risks, and doing the hard work to turn novel ideas into reality. Sophie doesn’t just react to the world around her; she evolves it.

Some ideas don’t unfold the way we expect but they always open the door to something new, often more powerful than what we imagined.

Paradigm Shifter

Alex Sneider

Principal

I pioneer to change the world, to achieve alongside incredible people, and to challenge myself intellectually.

Alex Sneider is a Principal at Flagship Pioneering, where she plays a multifaceted role in driving transformative scientific advancements. She creates and builds new companies while shaping the future of scientific exploration. As a founding team member of Flagship-founded Lila Sciences, Alex leads corporate development, forging partnerships and unlocking the company’s commercial potential. Lila is redefining scientific discovery by creating the world’s first scientific superintelligence platform and fully autonomous labs for life, chemical, and materials sciences.

Lila is an endless playground for scientific discovery. It represents a paradigm shift in how we approach problem-solving to tackle humanity's greatest challenges.

Alex’s journey to Flagship was one of reinvention and determination. She studied archaeology at Harvard, where her exploration of past civilizations sparked an appreciation for science’s ability to shape the future. This realization led her to pivot to technology recruiting. However, placing others in problem-solving roles wasn’t enough — she wanted to solve those problems herself.

Determined to pursue a more hands-on scientific career, Alex earned a second bachelor's degree in chemical engineering from the University of Massachusetts Lowell. A professor’s trust gave her early access to hands-on research, guiding her path and inspiring her passion for scientific discovery. This was followed by a Ph.D. at Johns Hopkins University in chemical and biomolecular engineering. During graduate school, an injury temporarily sidelined her from lab work. Undeterred, she taught herself to code and turned to AI and machine learning to finish her research.

A former athlete and Division I fencer, Alex is intentional about making time for hiking and other hobbies that keep her active but also provide space for reflection. "Sometimes, when you step away from a challenging question, the answers come more easily," she observes.

When asked about her pioneering role model, Alex points to the iconic movie character Indiana Jones — an archaeologist, academic and adventurer, whose courage, curiosity, and resourcefulness echo her own passion to transform and evolve scientific discovery in ways that solve humankind's most pressing challenges.

I want to change the world in a meaningful way. I hope the therapies and materials we discover at Lila bring positive benefits that pave the way for a brighter future.

Risk Weaver

Hozefa Bandukwala

Vice President and Science Partner

I pioneer because I have faith. With the talent, vision and courage we have at Flagship, a simple question drives me: ‘If not us, then who?’

Hozefa Bandukwala is a Vice President, Science Partner at Flagship Pioneering, where he explores ideas and founds new companies. One of his key accomplishments is co-founding Prologue Medicines, where he is the founding Chief Scientific Officer. In this role, he leads efforts to create transformative medicines by discovering and evaluating viral proteins and their unique features.

Hozefa’s passion for science began during his undergraduate studies in India when he came across an article in Scientific American about missile-like drug delivery systems — now known as antibody drug conjugates (ADCs). The ingenuity of leveraging the immune system for therapeutic purposes fascinated him. Until then, he had considered a medical career, but this moment shifted his path toward scientific pioneering.

While completing his Ph.D., Hozefa took a bold risk in his research on receptor-ligand interactions and pursued a hypothesis that defied conventional views. For four years, his data supported his idea — until one critical experiment disproved his theory. Though a devastating setback, instead of giving up, Hozefa reinterpreted his valid observations, leading to a breakthrough in allergy and asthma research that earned an article in The Journal of Experimental Medicine. Ultimately, he learned the importance of taking risks and that failure is a step toward discovery.

It's not how many times you fail, it's how many times you get back up.

This mindset led him to Pfizer during a critical time for immune-related disease research. While most therapeutic research focused on targeting immune cells, he proposed a non-conventional approach of targeting their energy sources by studying metabolic pathways; a concept initially met with some valid concerns about the novelty of this approach. Hozefa learned that overcoming resistance to change demands the ability to bring people along, unite diverse perspectives, and address concerns. His skill in rallying support was pivotal in driving Pfizer to invest in pioneering in the nascent field of immunometabolism which later grew to become an entire academic movement.

Hozefa sees equitable access as the next critical frontier in healthcare, a disparity he would like to tackle and make a lasting change. While medicine has advanced from treatment to cures and prevention, access to transformative therapies remains limited, benefiting only a portion of the population. He believes that pioneering bold, innovative science and risk-taking will be essential in making this a reality.

You cannot do transformational things by doing the same thing over and over again. To make that kind of impact, you have to do something different. You have to take that risk.

Why I
Pioneer

Impact Seeker

Impact Seeker

Metabolic Maverick

Metabolic Maverick

Mindset Trainer

Mindset Trainer

Imagination Agent

Imagination Agent

Cure Hunter

Cure Hunter

Innovation Enabler

Innovation Enabler

Biotech Surfer

Biotech Surfer

Curious Collaborator

Curious Collaborator

Polydisciplinarian

Polydisciplinarian

Resource Diviner

Resource Diviner

Scientific Storyteller

Scientific Storyteller

Evolutionary

Evolutionary

Paradigm Shifter

Paradigm Shifter

Risk Weaver

Risk Weaver

Jobs at Flagship Pioneering and our companies

Why I Pioneer

Impact Seeker

Metabolic Maverick

Mindset Trainer

Imagination Agent

Cure Hunter

Innovation Enabler

Biotech Surfer

Curious Collaborator

Polydisciplinarian

Resource Diviner

Scientific Storyteller

Evolutionary

Paradigm Shifter

Risk Weaver

Jobs at Flagship Pioneering and our companies

Why I
Pioneer